Cardiologist @AtriumHealth. @VUMC_heart trained / @nyulangone IM chief / proud @DukeU alum. Interested in medical humanities & cardio-onc. tweets are my own
Charlotte, NC
Joined June 2010
- Tweets677
- Following316
- Followers355
- Likes952
Pinned Tweet
🫀 Patients with cancer are showing up in every corner of cardiology - are you ready?
⚡️ Join our 3rd Annual Cardio-Oncology Symposium! #cardioonc
🗓️ Sat Oct 17th | 8-4 | HYBRID
🌟 Complex Cases | Expert Panels | Modern Management
☑️ CME/MOC!
👉 REGISTER: 2026shvicardioonc.eventscrib…
Amar Parikh retweeted
Truly special conference with several colleagues delivering some of the best ways to deliver multidisciplinary care in #cardioonc. For those who missed my talk. I discussed the tool we developed to take care of #prostatecancer @PCF_Science @neerajaiims Cardonc-guideline.com/calcul…
Another STELLAR #cardioonc @AtriumHealth conf by @JaiSingh_MD @amar_parikh & a super 🌟 lineup & brilliant setup
What makes this mtg stand out is that it emphasizes managing ❤️ Disease in cancer.
That ALL cardiologists play a part in this team sport, beyond our “niche” group👏
Amar Parikh retweeted
Truly a spectacular symposium. Clinically relevant, learned something new each session and got to catch up and meet some of the best cardio-onc leaders. Thank you @JaiSingh_MD and @amar_parikh for the opportunity to be involved! #cardioonc
Another STELLAR #cardioonc @AtriumHealth conf by @JaiSingh_MD @amar_parikh & a super 🌟 lineup & brilliant setup
What makes this mtg stand out is that it emphasizes managing ❤️ Disease in cancer.
That ALL cardiologists play a part in this team sport, beyond our “niche” group👏
Amar Parikh retweeted
Congrats to @JaiSingh_MD & @amar_parikh on a fantastic 3rd Annual Cardio-Oncology Symposium @AtriumSHVI! Practical, case-based learning from amyloid to valve disease in cancer. #CardioOnc
Amar Parikh retweeted
Another STELLAR #cardioonc @AtriumHealth conf by @JaiSingh_MD @amar_parikh & a super 🌟 lineup & brilliant setup
What makes this mtg stand out is that it emphasizes managing ❤️ Disease in cancer.
That ALL cardiologists play a part in this team sport, beyond our “niche” group👏
Amar Parikh retweeted
Excited to be a part of this amazing event! Looking forward to discussing the nuances of pulmonary embolism care in patients with cancer.
#cardioonc #pert
🫀 Patients with cancer are showing up in every corner of cardiology - are you ready?
⚡️ Join our 3rd Annual Cardio-Oncology Symposium! #cardioonc
🗓️ Sat Oct 17th | 8-4 | HYBRID
🌟 Complex Cases | Expert Panels | Modern Management
☑️ CME/MOC!
👉 REGISTER: 2026shvicardioonc.eventscrib…
Amar Parikh retweeted
PARADIGM in @NEJM reframes the assumption that intensive chemo is always optimal for fit patients with non-favorable-risk AML—preparing the way for more personalized treatment approaches that may offer greater efficacy with less toxicity. Proud to be part of this effort!! #leusm
In a randomized phase 2 trial involving adults with AML, azacitidine–venetoclax led to longer event-free survival than induction chemotherapy, with a lower risk of severe infection and hemorrhage. Full PARADIGM trial results: nej.md/4zJr1wV
Editorial: Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML nej.md/4cgnBHO
ALT Shown are Kaplan–Meier curves for event-free survival (Panel A) and overall survival (Panel B) in the azacitidine–venetoclax and induction chemotherapy groups.
Amar Parikh retweeted
How long do I have to stay on meds after CTRCD? In HER SAFE carefully selected population it was safe to stop. Huge Congratulations @dr_manisty and her mentees on this important practice-informingbstudy!#ESCCongress @ehj_ed
Heart function stayed stable at 1 year after carefully monitored withdrawal of heart failure therapy in breast cancer survivors with recovered anti-HER2 cardiotoxicity. Work from our group at @ucl, presented by @bmdwsg as a Late-Breaking Trial at #ESCCongress 2026 & published simultaneously in @ehj_ed: HER-SAFE. @TheBHF @escardio @MycardiumAI #CardioOnc
🔗 academic.oup.com/eurheartj/a…
Amar Parikh retweeted
🚨 Two randomized #CardioOncology trials at #ESCCongress2026!
🫀 RADICAL PC2: CV referral improved risk-factor control in prostate cancer.
💗 HER-SAFE: HF therapy withdrawal after recovery from anti-HER2 CTRCD appeared safe at 12 months.
@escardio @ESC_Journals
Amar Parikh retweeted
One of the phenomenal multidisciplinary #cardioonc symposiums of the year. @amar_parikh @JaiSingh_MD demonstrate not only the fascinating & complex cases that define cardio-oncology, but the critical relevance for ALL of cardiology & oncology to manage & learn from these cases.
🫀 Patients with cancer are showing up in every corner of cardiology - are you ready?
⚡️ Join our 3rd Annual Cardio-Oncology Symposium! #cardioonc
🗓️ Sat Oct 17th | 8-4 | HYBRID
🌟 Complex Cases | Expert Panels | Modern Management
☑️ CME/MOC!
👉 REGISTER: 2026shvicardioonc.eventscrib…
🚨Excited to share our @ACCinTouch Expert Review on managing ICI myocarditis in the CCU
⚡️Immunomodulation, MCS, PLEX - we break down a practical approach to a high-risk, complex syndrome
acc.org/Latest-in-Cardiology…
@RCH_MD @JaiSingh_MD @PalaskasN @datsunian @AnaBaracCardio
Amar Parikh retweeted
Congratulations on a phenomenal #CardioOnc Symposium @amar_parikh & @JaiSingh_MD ! Fantastic cases, multidisciplinary clinical panel discussion on daily challenges- showing how to take the education and teamwork to another level!! Thank you for inviting me!
Amar Parikh retweeted
A 🔥 @AtriumHealth @advocatehealth #cardioonc symposium led by @JaiSingh_MD @amar_parikh!
A 🤯 feat of balancing #cardioonc, cancer, & ♥️ disease in a forum that engages EVERYONE in cardiology, not just our tribe.
Excited to see this 🚀
🙏 for letting us be a part of this!!
Amar Parikh retweeted
@JaiSingh_MD & @amar_parikh are 2 of the best clinical fellows I have trained in #CardioOnc! Excited to be at this meeting in October! Will be an A+ and practical meting to approach to our patients! Looks forward 2 see everyone there! Register today! @ICOSociety @AtriumHealth
🚨 Cancer patients are showing up in every cardiology clinic - are you ready?
🧠 Join us for our 2nd Annual Cardio-Oncology Symposium! #cardioonc
🌟 National Experts + Complex Cases
🗓️ Sat Oct 11th 8am-4pm (hybrid)
✅ CME/MOC+APP/Pharm/RN (CE)
👉REGISTER: site.pheedloop.com/event/SHV…
Amar Parikh retweeted
These guys get it! Don’t miss this meeting if you are interested in great clinical #cardiooncology insights from leaders in our field.
🚨 Cancer patients are showing up in every cardiology clinic - are you ready?
🧠 Join us for our 2nd Annual Cardio-Oncology Symposium! #cardioonc
🌟 National Experts + Complex Cases
🗓️ Sat Oct 11th 8am-4pm (hybrid)
✅ CME/MOC+APP/Pharm/RN (CE)
👉REGISTER: site.pheedloop.com/event/SHV…
Amar Parikh retweeted
Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD @JACCJournals @ksase @dineshpmcc1 @ICOSociety
Amar Parikh retweeted
@AtriumHealth @amar_parikh #jaisingh have put together a 🔥 multidisciplinary #cardioonc conference that unites ALL fields of ♥️, showing the relevance of cancer to not just our "niche", but its⬆️ overlap with CVD.
Don't miss this amazing meeting!
@ICOSociety @Richardkcheng2
🚨 Cancer patients are showing up in every cardiology clinic - are you ready?
🧠 Join us for our 2nd Annual Cardio-Oncology Symposium! #cardioonc
🌟 National Experts + Complex Cases
🗓️ Sat Oct 11th 8am-4pm (hybrid)
✅ CME/MOC+APP/Pharm/RN (CE)
👉REGISTER: site.pheedloop.com/event/SHV…
🚨 Cancer patients are showing up in every cardiology clinic - are you ready?
🧠 Join us for our 2nd Annual Cardio-Oncology Symposium! #cardioonc
🌟 National Experts + Complex Cases
🗓️ Sat Oct 11th 8am-4pm (hybrid)
✅ CME/MOC+APP/Pharm/RN (CE)
👉REGISTER: site.pheedloop.com/event/SHV…